IperionX (IPX) Projected to Announce Quarterly Earnings on Wednesday

Key Points

• IperionX is expected to report H2 2026 earnings on September 23, with analysts projecting a loss of $0.0725 per share and revenue of approximately $1.49 million.
• IPX shares opened at $18.16, near their 12-month low of $17.40 and well below the 12-month high of $61.45. The stock carries a consensus “Moderate Buy” rating and an average analyst price target of $46.50.
• Company insiders have been buying shares: executives and directors purchased 663,720 shares worth about $2.38 million over the past 90 days, including substantial purchases by the CEO and chairman.

IperionX (NASDAQ:IPX - Get Free Report) is anticipated to announce its H2 2026 results before the market opens on Wednesday, September 23rd. Analysts expect IperionX to announce earnings of ($0.0725) per share and revenue of $1.4930 million for the quarter. Interested persons can check the company's upcoming H2 2026 earning report page for the latest details on the call scheduled for Tuesday, September 29, 2026 at 7:00 PM ET.

IperionX Stock Up 0.2%

Shares of NASDAQ:IPX opened at $18.16 on Wednesday. The company has a quick ratio of 4.00, a current ratio of 4.03 and a debt-to-equity ratio of 0.03. IperionX has a twelve month low of $17.40 and a twelve month high of $61.45. The stock's 50 day moving average is $22.47 and its 200-day moving average is $30.06.

Analyst Ratings Changes

A number of brokerages have commented on IPX. Weiss Ratings restated a "sell (e+)" rating on shares of IperionX in a research note on Friday, July 17th. Jefferies Financial Group assumed coverage on shares of IperionX in a research note on Wednesday, September 2nd. They issued a "buy" rating and a $26.00 price objective on the stock. BTIG Research lifted their price objective on shares of IperionX from $40.00 to $55.00 and gave the company a "buy" rating in a report on Friday, June 5th. Finally, Roth Capital set a $53.00 price objective on shares of IperionX in a report on Wednesday, August 5th. Six investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $46.50.

Insider Buying and Selling

In related news, CEO Anastasios Arima purchased 138,720 shares of the firm's stock in a transaction that occurred on Friday, July 10th. The stock was acquired at an average price of $3.58 per share, for a total transaction of $496,617.60. Following the completion of the acquisition, the chief executive officer owned 12,455,502 shares of the company's stock, valued at $44,590,697.16. This represents a 1.13% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Todd Hannigan purchased 300,000 shares of the stock in a transaction that occurred on Monday, July 13th. The stock was bought at an average cost of $3.59 per share, with a total value of $1,077,000.00. Following the completion of the transaction, the chairman directly owned 26,633,334 shares in the company, valued at $95,613,669.06. The trade was a 1.14% increase in their position. The SEC filing for this purchase provides additional information. Insiders bought 663,720 shares of company stock worth $2,379,118 in the last 90 days.

About IperionX

IperionX Limited NASDAQ: IPX is a materials technology company focused on developing a low-carbon, fully integrated titanium supply chain in the United States. The company is working to produce titanium metal and titanium products from locally sourced mineral resources, with applications across the aerospace, defense, automotive, medical and consumer industries.

IperionX's flagship asset is the Titan Project in Tennessee, which contains titanium, rare earth and zircon-rich mineral sands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.